Last reviewed · How we verify
DEX IR tablets
DEX IR tablets are a type of dextroamphetamine, a central nervous system stimulant that works by increasing the levels of certain neurotransmitters in the brain.
DEX IR tablets are a type of dextroamphetamine, a central nervous system stimulant that works by increasing the levels of certain neurotransmitters in the brain. Used for Attention deficit hyperactivity disorder (ADHD), Narcolepsy.
At a glance
| Generic name | DEX IR tablets |
|---|---|
| Sponsor | Prof. Dr. Frank Behrens |
| Drug class | Central nervous system stimulant |
| Modality | Small molecule |
| Therapeutic area | Attention deficit hyperactivity disorder (ADHD), Narcolepsy |
| Phase | Phase 2 |
Mechanism of action
Dextroamphetamine is a potent stimulant that increases the release of dopamine and norepinephrine in the brain, leading to increased alertness, attention, and energy. It also has some effects on serotonin levels, which may contribute to its therapeutic effects.
Approved indications
- Attention deficit hyperactivity disorder (ADHD)
- Narcolepsy
Common side effects
- Insomnia
- Dry mouth
- Headache
- Nervousness
- Dizziness
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DEX IR tablets CI brief — competitive landscape report
- DEX IR tablets updates RSS · CI watch RSS
- Prof. Dr. Frank Behrens portfolio CI